-
-
-
-
-
-
-
Silo Pharma comments on federal psychedelic therapy initiatives
-
-
-
-
-
-
-
Silo Pharma purchases ResearchCoin tokens for digital asset strategy
-
-
-
-
-
-
-
Silo Pharma expects preclinical data for PTSD drug SPC-15 within 90 days
-
-
-
-
-
-
-
Silo Pharma, Inc. (SILO) Prices 3.33M Share Offering at $0.6/sh
-
-
-
-
-
-
-
Silo Pharma (SILO) Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment
-
-
-
-
-
-
-
Silo Pharma (SILO) Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
-
-
-
-
-
-
-
Silo Pharma (SILO) Secures Exclusive Global License for Alzheimer's Therapeutic
-
434,563 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

